Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Desoximetasone
Drug ID BADD_D00620
Description A topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc.
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Marketing Status Prescription; Discontinued
ATC Code D07AC03; D07XC02
DrugBank ID DB00547
KEGG ID D03697
MeSH ID D003899
PubChem ID 5311067
TTD Drug ID D0CZ1Q
NDC Product Code 68788-7703; 50090-3919; 51672-5204; 51927-0187; 68180-946; 0472-0479; 51672-1396; 0168-0180; 51672-1261; 51672-1270; 51672-5203; 68382-889; 51672-1262; 68788-7695; 70771-1437; 68180-944; 0472-0478; 45802-807; 68180-948; 68180-949; 51672-1271; 0168-0151; 0713-0657; 71205-271; 51672-1352; 63629-8702; 52565-030; 51672-5202; 68180-950; 70771-1166; 51672-5281; 45802-496; 72578-095; 52565-045; 68462-531; 22552-0008; 50090-5571; 63629-8642; 53002-9280; 64980-326; 63187-646; 45802-495; 40032-024; 50090-0597; 64980-327; 72578-091; 63629-8641; 82298-112; 51672-5205; 46439-8706; 51672-5263
Synonyms Desoximetasone | Desoxymethasone | 17-Desoxymethasone | 17 Desoxymethasone | Deoxydexamethasone | Topicort | Stiedex | A-41304 | A 41304 | A41304 | Ibaril | Topisolon | Flubason | Topicorte | Desoxi
Chemical Information
Molecular Formula C22H29FO4
CAS Registry Number 140218-14-0
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001--Not Available
Application site irritation12.07.01.003; 08.02.01.003--Not Available
Application site pruritus23.03.12.004; 12.07.01.005; 08.02.01.005--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cataract subcapsular06.06.01.002--Not Available
Cushing's syndrome14.11.01.007; 05.01.01.001; 24.08.04.001; 19.07.03.002--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dermatitis infected11.01.12.011; 23.03.04.024--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis23.09.04.007; 11.01.12.018--
Glycosuria20.02.01.005--
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Pain08.01.08.004--
Pruritus23.03.12.001--
Psoriasis23.03.14.002; 10.02.01.036--Not Available
Pyoderma11.01.12.009; 23.09.01.007--Not Available
Secondary adrenocortical insufficiency14.11.01.014; 05.01.02.003--Not Available
Skin atrophy23.01.05.001--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia23.06.03.001; 24.03.03.003--
Skin maceration23.03.03.016--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages